The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Prospects for Control of Herpes Simplex Virus Disease through Immunization
Abstract
Herpes simplex viruses (HSVs) can cause a variety of infections, including genital herpes. Despite effective antiviral therapy, HSV infections remain a significant worldwide public health problem. Vaccines offer the best hope for controlling spread and limiting HSV disease. This article discusses the pathogenesis and immunobiology of mucocutaneous HSV infections, summarizes the spectrum of diseases caused by HSV, and provides a review of the field of HSV vaccine research. This article also discusses what might be realistically expected of a vaccine intended for control of genital herpes and explores the question of whether a vaccine that is effective in controlling genital HSV disease might also be effective in controlling nongenital HSV disease. The efficacy of such vaccines for the full spectrum of HSV disease will eventually determine the timing and targeting of immunization, ranging from selective immunization in preadolescence to universal childhood immunization as part of the routine childhood regimen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ACYCLOVIR VERSUS VIDARABINE IN HERPES SIMPLEX ENCEPHALITIS
Sköldenberg, B., Alestig, K., Burman, L., Forkman, A., Lövgren, K., Norrby, R., Stiernstedt, G., Forsgren, M., Bergström, T., Dahlqvist, E., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92623-0 · Cited by 610 · cited 1×
“Most cases are probably due to reactivation of latent HSV-1, since ∼70% of subjects with HSV encephalitis are seropositive at presentation [139, 140].”
BackgroundBrown, Z. A., Benedetti, J., Ashley, R., Burchett, S., Selke, S., Berry, S., Vontver, L. A., & Corey, L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105023241804 · Cited by 473
Herpes simplex encephalitis: long term magnetic resonance imaging and neuropsychological profile.
Kapur, N., Barker, S., Burrows, E. H., Ellison, D., Brice, J., Illis, L. S., Scholey, K., Colbourn, C., Wilson, B., & Loates, M. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.11.1334 · Cited by 224
Cited by
Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S., Tyring, S., Aoki, F. Y., Slaoui, M., Denis, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011915 · Cited by 794
Self-citationWhitley, R. J., & Roizman, B. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0597 · Cited by 700
An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection
Looker, K. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.046128 · Cited by 493
Herpes Simplex Virus Type 1 infection: overview on relevant clinico‐pathological features*
Arduino, P. G., & Porter, S. R. (2008) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2007.00586.x · Cited by 431
Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research
Koelle, D. M., & Corey, L. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.96-113.2003 · Cited by 263
Metadata
- Authors
- Stanberry, L. R., Cunningham, A. L., Mindel, A., Scott, L. L., Spruance, S. L., Aoki, F. Y., & Lacey, C. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-03-01
- Volume
- 30
- Issue
- 3
- Pages
- 549-566
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2110933237
- Cited by
- 200
- References
- 3
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prospects for Control of Herpes Simplex Virus Disease through Immunization. https://app.cochat.ai/papers/10.1086/313687
- The paper
- Stanberry, L. R., Cunningham, A. L., Mindel, A., Scott, L. L., Spruance, S. L., Aoki, F. Y., & Lacey, C. J. (2000). Prospects for Control of Herpes Simplex Virus Disease through Immunization. Clinical Infectious Diseases. https://doi.org/10.1086/313687
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.